Advocacy groups urge Biden administration not to tap Woodcock as FDA commissioner

Stat News

27 January 2021 - As the Biden White House attempts to fashion its health policies, a coalition of consumer and patient advocacy groups is urging the administration not to tap Janet Woodcock, a long-standing FDA official, to head the embattled agency.

Woodcock is currently serving as acting FDA commissioner, but has at various times led the division that regulates medicines.

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Management